RankAlpha logo
Back to Rankings

ENTA

EnantaC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
ENTA vs peer average
56/100
ENTA vs. peer average (C vs. C)
Grade spread
A 1 · B 2 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

LYEL is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $347.45M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerLYELLyell Immunopharma
ENTA
Enanta
LYEL
Lyell Immunopharma
Grade
C
F
Momentum
59
6
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs LYEL

ENTA / LYEL
Grade Position
In line
ENTA vs. peer average (C vs. C)
56/100
Momentum
59
ENTA
Value
41
ENTA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ENTA
1
LYEL
Lyell Immunopharma Inc Common
F
20/100
+2
2
FENC
Fennec Pharmaceuticals Inc Common
A
100/100
-2
3
LXEO
Lexeo Therapeutics Inc Common
F
20/100
+2
4
PBYI
Puma Biotechnology Inc Common
B
80/100
-1
5
GLSI
Greenwich LifeSciences Inc Common
B
80/100
-1
LYEL is the first peer returned for this comparison set.